» Articles » PMID: 25764541

Altered Gut Microbial Energy and Metabolism in Children with Non-alcoholic Fatty Liver Disease

Overview
Date 2015 Mar 13
PMID 25764541
Citations 148
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is becoming the new pediatric epidemic. Non-alcoholic fatty liver disease (NAFLD) is frequently associated with obesity and has become the most common cause of pediatric liver disease. The gut microbiome is the major metabolic organ and determines how calories are processed, serving as a caloric gate and contributing towards the pathogenesis of NAFLD. The goal of this study is to examine gut microbial profiles in children with NAFLD using phylogenetic, metabolomic, metagenomic and proteomic approaches. Fecal samples were obtained from obese children with or without NAFLD and healthy lean children. Stool specimens were subjected to 16S rRNA gene microarray, shotgun sequencing, mass spectroscopy for proteomics and NMR spectroscopy for metabolite analysis. Children with NAFLD had more abundant Gammaproteobacteria and Prevotella and significantly higher levels of ethanol, with differential effects on short chain fatty acids. This group also had increased genomic and protein abundance for energy production with a reduction in carbohydrate and amino acid metabolism and urea cycle and urea transport systems. The metaproteome and metagenome showed similar findings. The gut microbiome in pediatric NAFLD is distinct from lean healthy children with more alcohol production and pathways allocated to energy metabolism over carbohydrate and amino acid metabolism, which would contribute to development of disease.

Citing Articles

Targeted Sodium Acetate Liposomes for Hepatocytes and Kupffer Cells: An Oral Dual-Targeted Therapeutic Approach for Non-Alcoholic Fatty Liver Disease Alleviation.

Hou Y, Gao X, Gong J, Dong X, Hao Y, Zhai Z Nutrients. 2025; 17(5).

PMID: 40077800 PMC: 11901740. DOI: 10.3390/nu17050930.


Early childhood adiposity, lifestyle and gut microbiome are linked to steatotic liver disease development in adolescents.

Cai C, Zhang Z, Alberti G, Pereira A, De Barbieri F, Garcia C Int J Obes (Lond). 2025; .

PMID: 40075127 DOI: 10.1038/s41366-025-01737-1.


Advances in multi-omics integrated analysis methods based on the gut microbiome and their applications.

Duan D, Wang M, Han J, Li M, Wang Z, Zhou S Front Microbiol. 2025; 15():1509117.

PMID: 39831120 PMC: 11739165. DOI: 10.3389/fmicb.2024.1509117.


sp. for the Attenuation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice.

Olotu T, Ferrell J Microorganisms. 2025; 12(12.

PMID: 39770690 PMC: 11728176. DOI: 10.3390/microorganisms12122488.


Comparative analysis of gut microbiota in metabolic syndrome and obese children from Southeastern China.

Wang J, Zhuang P, Lin B, Zheng J, Li H, Tang W Front Microbiol. 2025; 15:1503302.

PMID: 39764447 PMC: 11701008. DOI: 10.3389/fmicb.2024.1503302.


References
1.
Ogden C, Carroll M, Curtin L, McDowell M, Tabak C, Flegal K . Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006; 295(13):1549-55. DOI: 10.1001/jama.295.13.1549. View

2.
Backhed F, Manchester J, Semenkovich C, Gordon J . Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A. 2007; 104(3):979-84. PMC: 1764762. DOI: 10.1073/pnas.0605374104. View

3.
Sonnenburg J, Xu J, Leip D, Chen C, Westover B, Weatherford J . Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science. 2005; 307(5717):1955-9. DOI: 10.1126/science.1109051. View

4.
Backhed F, Ding H, Wang T, Hooper L, Koh G, Nagy A . The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004; 101(44):15718-23. PMC: 524219. DOI: 10.1073/pnas.0407076101. View

5.
White D, Kanwal F, El-Serag H . Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol. 2012; 10(12):1342-1359.e2. PMC: 3501546. DOI: 10.1016/j.cgh.2012.10.001. View